Gossamer Bio extends early tender deadline for exchange offer; $181M of notes tendered

Gossamer Bio, Inc.

Early tender deadline extended to 5:00 p.m. ET on June 2, 2026; early settlement expected June 4, 2026.
$181,052,000 in aggregate principal of 5.00% Convertible Senior Notes due 2027 validly tendered as of June 1.
Exchange offer requires minimum 98% of aggregate principal to be tendered; withdrawal deadline expired June 1.
New 7.50% Convertible Senior Secured First Lien Notes due 2030 offered, up to $72.0M principal.
Up to 317,647,058 shares of common stock (or prefunded warrants) offered as part of exchange consideration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.